InjectionMRP Under Process
Official PMBI MRP is being updated for catalog code 2774.
Locate Jan Aushadhi KendraClinical Overview
Fluconazole is a synthetic bistriazole antifungal agent on the WHO Model List of Essential Medicines. It selectively inhibits fungal lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis with 100-fold higher affinity for fungal enzymes than human CYP450. Features exceptional water solubility, high oral bioavailability (>90%), and long half-life (around 30 hours). Indicated for vaginal candidiasis, mucosal candidiasis (oropharyngeal, esophageal), cryptococcal meningitis, tinea pedis/corporis/cruris, and candidal prophylaxis in immunocompromised patients.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Administered by a licensed healthcare professional by continuous intravenous infusion at a maximum rate of 200 mg/hour (approx 100 mL/hr). Do not push IV.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Nausea, abdominal discomfort, headache, diarrhea, mild rash, elevated liver enzymes. Rare/Severe: Severe hepatic toxicity/jaundice, QT interval prolongation and torsades de pointes, Stevens-Johnson syndrome, and anaphylaxis.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in patients with known hypersensitivity to azoles and concurrent administration with terfenadine or cisapride. Use with caution in patients with renal impairment (dose reduction required) or cardiac arrhythmias. Avoid in pregnancy (teratogenic risk with high/prolonged doses).
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered dermatologist or qualified medical practitioner before initiating, altering, or substituting any topical or systemic dermatological treatment.
Fluconazole Tablets 150 mg
Fluconazole is a synthetic bistriazole antifungal agent on the WHO Model List of Essential Medicines. It selectively inhibits fungal lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis with 100-fold higher affinity for fungal enzymes than human CYP450. Features exceptional water solubility, high oral bioavailability (>90%), and long half-life (around 30 hours). Indicated for vaginal candidiasis, mucosal candidiasis (oropharyngeal, esophageal), cryptococcal meningitis, tinea pedis/corporis/cruris, and candidal prophylaxis in immunocompromised patients.
Voriconazole Tablets 200mg
Fluconazole is a synthetic bistriazole antifungal agent on the WHO Model List of Essential Medicines. It selectively inhibits fungal lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis with 100-fold higher affinity for fungal enzymes than human CYP450. Features exceptional water solubility, high oral bioavailability (>90%), and long half-life (around 30 hours). Indicated for vaginal candidiasis, mucosal candidiasis (oropharyngeal, esophageal), cryptococcal meningitis, tinea pedis/corporis/cruris, and candidal prophylaxis in immunocompromised patients.
Fluconazole Dusting Powder 2%
Fluconazole is a synthetic bistriazole antifungal agent on the WHO Model List of Essential Medicines. It selectively inhibits fungal lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis with 100-fold higher affinity for fungal enzymes than human CYP450. Features exceptional water solubility, high oral bioavailability (>90%), and long half-life (around 30 hours). Indicated for vaginal candidiasis, mucosal candidiasis (oropharyngeal, esophageal), cryptococcal meningitis, tinea pedis/corporis/cruris, and candidal prophylaxis in immunocompromised patients.
Fluconazole Tablets 50 mg
Fluconazole is a synthetic bistriazole antifungal agent on the WHO Model List of Essential Medicines. It selectively inhibits fungal lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis with 100-fold higher affinity for fungal enzymes than human CYP450. Features exceptional water solubility, high oral bioavailability (>90%), and long half-life (around 30 hours). Indicated for vaginal candidiasis, mucosal candidiasis (oropharyngeal, esophageal), cryptococcal meningitis, tinea pedis/corporis/cruris, and candidal prophylaxis in immunocompromised patients.